• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种微流控方法制备蔗糖修饰的脂质体,可增加乳腺癌细胞的摄取。

A microfluidic approach to fabricate sucrose decorated liposomes with increased uptake in breast cancer cells.

机构信息

Department of Biomolecular Sciences, University of Urbino Carlo Bo, Piazza del Rinascimento, 6, 61029 Urbino, (PU), Italy.

Department of Biomolecular Sciences, University of Urbino Carlo Bo, Piazza del Rinascimento, 6, 61029 Urbino, (PU), Italy.

出版信息

Eur J Pharm Biopharm. 2022 Sep;178:53-64. doi: 10.1016/j.ejpb.2022.07.015. Epub 2022 Jul 30.

DOI:10.1016/j.ejpb.2022.07.015
PMID:35917863
Abstract

Developing targeted drug delivery systems is an urgent need to decrease the side effects and increase the drug's efficiency. Most cancer cells show an increased sugar consumption compared to healthy cells due to the deregulation of sugar transporters. Consequently, liposomes, as a biocompatible nanocarrier, could be surface decorated by sugars to enhance drug targeting into cancer cells. Our work outlines a new strategy to easily manufacture sucrose decorated liposomes using sucrose stearate, a biocompatible and biodegradable non-ionic surfactant, with a scalable microfluidic approach. Sucrose decorated liposomes were loaded with berberine hydrochloride, a well-known phytochemical compound to investigate its effects on triple-negative breast cancer cells (MDA-MB-231). Using the microfluidic manufacturing system, we prepared berberine-loaded liposomes using a mixture of phosphatidylcholine and cholesterol with and without sucrose stearate with a size up to 140 nm and narrow polydispersity. Stability was confirmed for 90 days, and the in vitro release profile was evaluated. The formulations showed acceptable in vitro biocompatibility and significantly higher anti-proliferative effect on MDA-MB-231 cell line. These results have been confirmed by an increased uptake evaluated by flow cytometry and confocal microscopy. Taken together, our findings represent an innovative, easy, and scalable approach to obtain sugar decorated liposomal formulations without any surface-chemistry reactions. They can be potentially used as an anticancer targeted drug delivery system.

摘要

开发靶向药物输送系统是降低副作用和提高药物效率的迫切需要。与健康细胞相比,大多数癌细胞由于糖转运蛋白的失调而显示出更高的糖消耗。因此,作为一种生物相容性的纳米载体,脂质体可以通过糖来表面修饰,以增强药物对癌细胞的靶向作用。我们的工作概述了一种使用蔗糖硬脂酸(一种生物相容和可生物降解的非离子表面活性剂)通过可扩展的微流控方法轻松制造蔗糖修饰脂质体的新策略。蔗糖修饰的脂质体被盐酸小檗碱(一种众所周知的植物化学化合物)装载,以研究其对三阴性乳腺癌细胞(MDA-MB-231)的作用。使用微流控制造系统,我们使用含有和不含有蔗糖硬脂酸的磷脂酰胆碱和胆固醇混合物制备了载有盐酸小檗碱的脂质体,其粒径高达 140nm 且具有较窄的多分散性。稳定性在 90 天内得到了确认,并评估了体外释放曲线。这些制剂表现出可接受的体外生物相容性,并且对 MDA-MB-231 细胞系的增殖抑制作用显著更高。这些结果通过流式细胞术和共聚焦显微镜评估的摄取增加得到了证实。总之,我们的研究结果代表了一种创新、简单且可扩展的方法,可以获得无需任何表面化学反应的糖修饰脂质体制剂。它们可能被用作抗癌靶向药物输送系统。

相似文献

1
A microfluidic approach to fabricate sucrose decorated liposomes with increased uptake in breast cancer cells.一种微流控方法制备蔗糖修饰的脂质体,可增加乳腺癌细胞的摄取。
Eur J Pharm Biopharm. 2022 Sep;178:53-64. doi: 10.1016/j.ejpb.2022.07.015. Epub 2022 Jul 30.
2
Microfluidic-assisted fabrication of phosphatidylcholine-based liposomes for controlled drug delivery of chemotherapeutics.用于化疗药物控释的基于磷脂酰胆碱的脂质体的微流控辅助制备
Int J Pharm. 2021 Jul 15;604:120711. doi: 10.1016/j.ijpharm.2021.120711. Epub 2021 May 18.
3
Manufacturing drug co-loaded liposomal formulations targeting breast cancer: Influence of preparative method on liposomes characteristics and in vitro toxicity.制备载药脂质体靶向乳腺癌制剂:制备方法对脂质体性质和体外毒性的影响。
Int J Pharm. 2020 Nov 30;590:119926. doi: 10.1016/j.ijpharm.2020.119926. Epub 2020 Oct 1.
4
Engineered peptides for the development of actively tumor targeted liposomal carriers of doxorubicin.用于开发主动靶向肿瘤的多柔比星脂质体载体的工程肽。
Cancer Lett. 2013 Jul 1;334(2):284-92. doi: 10.1016/j.canlet.2012.10.007. Epub 2012 Oct 13.
5
Manufacturing of 3D-Printed Microfluidic Devices for the Synthesis of Drug-Loaded Liposomal Formulations.3D 打印微流控器件用于载药脂质体制剂合成的制造。
Int J Mol Sci. 2021 Jul 28;22(15):8064. doi: 10.3390/ijms22158064.
6
Novel microfluidic swirl mixers for scalable formulation of curcumin loaded liposomes for cancer therapy.新型微流控旋流混合器用于可扩展制备姜黄素载脂质体用于癌症治疗。
Int J Pharm. 2022 Jun 25;622:121857. doi: 10.1016/j.ijpharm.2022.121857. Epub 2022 May 24.
7
Microfluidic synthesis of multifunctional liposomes for tumour targeting.用于肿瘤靶向的多功能脂质体的微流控合成
Colloids Surf B Biointerfaces. 2016 Dec 1;148:402-410. doi: 10.1016/j.colsurfb.2016.09.016. Epub 2016 Sep 12.
8
Microfluidic preparation of liposomes to determine particle size influence on cellular uptake mechanisms.用于确定粒径对细胞摄取机制影响的脂质体微流体制备方法。
Pharm Res. 2014 Feb;31(2):401-13. doi: 10.1007/s11095-013-1171-8. Epub 2013 Oct 3.
9
Hyperthermia-mediated drug delivery induces biological effects at the tumor and molecular levels that improve cisplatin efficacy in triple negative breast cancer.热疗介导的药物递送在肿瘤和分子水平上诱导生物学效应,提高三阴性乳腺癌中顺铂的疗效。
J Control Release. 2018 Jul 28;282:35-45. doi: 10.1016/j.jconrel.2018.04.029. Epub 2018 Apr 16.
10
Dexamethasone Loaded Liposomes by Thin-Film Hydration and Microfluidic Procedures: Formulation Challenges.薄膜水化法和微流控法制备地塞米松脂质体:制剂挑战。
Int J Mol Sci. 2020 Feb 26;21(5):1611. doi: 10.3390/ijms21051611.

引用本文的文献

1
Liposome-Encapsulated Antibiotics for the Therapy of Mycobacterial Infections.用于治疗分枝杆菌感染的脂质体包封抗生素
Antibiotics (Basel). 2025 Jul 20;14(7):728. doi: 10.3390/antibiotics14070728.
2
Development of a novel intramuscular liposomal injection for advanced meloxicam delivery: Preparation, characterization, pharmacokinetics, pharmacodynamics, and pain assessment in an orthopedic pain model.一种用于美洛昔康高级递送的新型肌肉注射脂质体的研发:在骨科疼痛模型中的制备、表征、药代动力学、药效学及疼痛评估
Int J Pharm X. 2024 Sep 14;8:100284. doi: 10.1016/j.ijpx.2024.100284. eCollection 2024 Dec.
3
Strategies for Improved pDNA Loading and Protection Using Cationic and Neutral LNPs with Industrial Scalability Potential Using Microfluidic Technology.
使用具有工业化放大潜力的微流控技术的阳离子和中性 LNPs 提高 pDNA 载量和保护的策略。
Int J Nanomedicine. 2024 May 14;19:4235-4251. doi: 10.2147/IJN.S457302. eCollection 2024.
4
Microfluidics-mediated Liposomal Nanoparticles for Cancer Therapy: Recent Developments on Advanced Devices and Technologies.微流控介导的脂质体纳米颗粒用于癌症治疗:先进设备和技术的最新进展。
Curr Top Med Chem. 2024;24(14):1185-1211. doi: 10.2174/0115680266286460240220073334.
5
Three-Dimensional Bioprinting in Cardiovascular Disease: Current Status and Future Directions.三维生物打印在心血管疾病中的应用:现状与未来方向。
Biomolecules. 2023 Jul 28;13(8):1180. doi: 10.3390/biom13081180.
6
Extracellular Vesicles as New Players in Drug Delivery: A Focus on Red Blood Cells-Derived EVs.细胞外囊泡作为药物递送的新参与者:聚焦于红细胞衍生的细胞外囊泡
Pharmaceutics. 2023 Jan 21;15(2):365. doi: 10.3390/pharmaceutics15020365.
7
3D Printing Technologies in Personalized Medicine, Nanomedicines, and Biopharmaceuticals.个性化医疗、纳米药物和生物制药中的3D打印技术
Pharmaceutics. 2023 Jan 17;15(2):313. doi: 10.3390/pharmaceutics15020313.